Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-111702

President and CEO sold 500 shares at $24.00 ($12,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd President and CEO 2024-09-30 Sale 10b5-1 −500 $24.00 $12,000 1,477,373 D
Open-market sales · 500 sh · avg $24.00 · $12,000
Loading xslF345X05/ownership.xml…